NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Kilitch Drugs (India) Limited (NSE: KILITCH)

 
KILITCH Technical Analysis
2
As on 8th May 2024 KILITCH SHARE Price closed @ 332.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 244.97 & Strong Sell for SHORT-TERM with Stoploss of 370.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KILITCHSHARE Price

Open 344.85 Change Price %
High 346.65 1 Day -8.05 -2.37
Low 327.20 1 Week -30.60 -8.44
Close 332.10 1 Month -42.60 -11.37
Volume 5591 1 Year 130.10 64.41
52 Week High 262.00 | 52 Week Low 80.25
 
NSE INDIA Most Active Stocks
IDEA 12.70 2.42%
YESBANK 22.95 0.44%
NHPC 98.85 1.80%
PNB 124.80 2.04%
IDFCFIRSTB 76.95 -1.16%
RTNPOWER 10.90 4.81%
RECLTD 534.00 5.32%
ZOMATO 195.45 2.09%
HUDCO 223.75 7.55%
IFCI 52.40 6.94%
 
NSE INDIA Top Gainers Stocks
SHIVAMILLS 110.70 20.00%
TFL 17.95 17.70%
TFL 17.95 17.70%
KECL 160.75 14.78%
BHARATFORG 1405.15 13.32%
PENINLAND 61.30 12.89%
SASKEN 1634.65 11.01%
DSSL 1268.50 10.00%
EXCEL 0.55 10.00%
IRIS 175.45 10.00%
 
NSE INDIA Top Losers Stocks
SONATSOFTW 540.05 -15.38%
BIGBLOC 247.55 -9.12%
JINDALSAW 532.05 -6.32%
HMVL 101.35 -5.85%
FLUOROCHEM 3306.70 -5.75%
STLTECH 124.65 -5.21%
CREATIVEYE 5.60 -5.08%
VOLTAS 1318.80 -5.07%
MACPOWER 1309.75 -5.00%
SHAKTIPUMP 2180.90 -5.00%
 
 
KILITCH
Daily Charts
KILITCH
Intraday Charts
Whats New @
Bazaartrend
KILITCH
Free Analysis
 
KILITCH Important Levels Intraday
RESISTANCE369.58
RESISTANCE357.56
RESISTANCE350.13
RESISTANCE342.70
SUPPORT321.50
SUPPORT314.07
SUPPORT306.64
SUPPORT294.62
 
KILITCH Target May 2024
4th UP Target590.24
3rd UP Target523.31
2nd UP Target481.94
1st UP Target440.57
1st DOWN Target322.53
2nd DOWN Target281.16
3rd DOWN Target239.79
4th DOWN Target172.86
 
KILITCH Weekly Target
4th UP Target436.23
3rd UP Target410.24
2nd UP Target394.18
1st UP Target378.12
1st DOWN Target332.28
2nd DOWN Target316.22
3rd DOWN Target300.16
4th DOWN Target274.17
 
KILITCH Target2024
4th UP Target424
3rd UP Target357.97
2nd UP Target317.15
1st UP Target276.33
1st DOWN Target159.87
2nd DOWN Target119.05
3rd DOWN Target78.23
4th DOWN Target12.2
 
 
KILITCH Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 39.69 Sideways
MFI (14) MFI is 53.36 Sideways
CCI (20) CCI is -46.39 Sideways
WILLIAM %R (14) William %R is -44.39 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 61.84
10 Day Avg Volume Traded -27.20 % Less then 10 Day Average Volume
 
KILITCH Other Details
Segment EQ
Market Capital 2549692160.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
KILITCH Address
KILITCH
 
KILITCH Latest News
 
Your Comments and Response on Kilitch Drugs (India) Limited
 
KILITCH Business Profile
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrups, gripe water, and oral powders and liquids in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India. Address: 37/39, Ujagar Industrial Estate, Mumbai, India, 400088
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service